Check out our most popular compounded medications! Get Started
Dantrolene Sodium 50 mg/ml Oral Liquid is a specially compounded medication designed for oral use, offering a precise and manageable method of drug delivery. This liquid formulation is particularly beneficial for patients who experience difficulty swallowing pills, such as those in pediatric and geriatric groups. Dantrolene Sodium is primarily used in the treatment of malignant hyperthermia, a life-threatening complication of certain anesthetic agents, and also for the management of muscle spasticity associated with conditions such as spinal cord injury, stroke, cerebral palsy, and multiple sclerosis.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Dantrolene Sodium is a muscle relaxant that works by directly affecting skeletal muscle function, thereby reducing the force of muscle contractions. This unique mechanism of action makes it particularly useful in the treatment of conditions characterized by excessive muscle contraction or spasticity. The 50 mg/ml oral liquid formulation of Dantrolene Sodium provides a specialized dosage form designed for ease of administration, especially beneficial for patients who have difficulty swallowing pills, such as those with dysphagia, or for specific patient groups like children and the elderly who may require tailored dosing or have issues with solid dosage forms.
The Dantrolene Sodium oral liquid is indicated for the management of clinical spasticity resulting from upper motor neuron disorders such as spinal cord injury, stroke, cerebral palsy, or multiple sclerosis. It is also the drug of choice for the treatment of malignant hyperthermia, a rare but life-threatening condition triggered by certain anesthetics and muscle relaxants. By providing the medication in a liquid form, the compounding pharmacists at Bayview Pharmacy ensure that the medication can be accurately dosed according to the specific needs of the patient, which is critical for both efficacy and safety.
For patients, it is important to understand that the liquid formulation allows for flexible dosing, which must be carefully followed as per the prescriber's instructions. The medication should be measured with an appropriate measuring device to ensure the correct dose is administered. For prescribers, the compounded Dantrolene Sodium oral liquid offers a way to customize treatment for patients with unique needs, ensuring that the therapeutic goals can be met with a patient-centric approach. Regular monitoring of liver function tests is recommended due to the potential hepatotoxicity associated with Dantrolene Sodium, especially with long-term use.
Bayview Pharmacy's team of compounding pharmacists is committed to providing high-quality, patient-specific formulations. We are available to answer any questions or concerns regarding the Dantrolene Sodium 50 mg/ml oral liquid, its administration, or its role in the management of specific disease states. Our goal is to support both patients and healthcare providers in achieving optimal therapeutic outcomes with our compounded medications.
Dantrolene Sodium is a muscle relaxant that works by affecting the flow of calcium in the muscle cells, thereby reducing the strength of the muscle contractions. It is primarily used in the treatment of conditions such as malignant hyperthermia, a life-threatening complication of certain anesthetic drugs, and for the management of muscle spasticity associated with spinal cord injury, stroke, cerebral palsy, or multiple sclerosis. When considering the use of Dantrolene Sodium 50 mg/ml Oral Liquid, it is crucial to be aware of potential drug interactions that may affect the efficacy of the medication or increase the risk of adverse effects.
One significant interaction is with central nervous system depressants, such as benzodiazepines, opioids, and barbiturates. Concurrent use of these medications with Dantrolene Sodium can lead to additive sedative effects, which may impair cognitive and motor functions. Patients should be monitored closely for signs of excessive sedation and dosage adjustments may be necessary. Alcohol should also be avoided as it can enhance the sedative and muscle relaxant effects of Dantrolene Sodium.
Patients receiving calcium channel blockers, particularly those used for the management of hypertension or cardiac conditions, should be monitored when starting Dantrolene Sodium. The combination can lead to an increased risk of cardiac depression and other cardiovascular effects. In some cases, this may necessitate a reduction in the dosage of the calcium channel blocker or careful monitoring of cardiac function.
Estrogen therapy, including oral contraceptives containing estrogen, can potentially increase the risk of hepatotoxicity associated with Dantrolene Sodium. Liver function should be monitored regularly, and alternative contraceptive methods may be considered. Additionally, the use of Dantrolene Sodium with other hepatotoxic drugs should be approached with caution, and periodic liver function tests are recommended.
Neuromuscular blocking agents used during surgery or certain medical procedures may have their effects potentiated by Dantrolene Sodium. This could lead to prolonged respiratory depression or muscle weakness. Anesthesiologists should be informed if a patient is taking Dantrolene Sodium so that they can adjust their anesthetic plan accordingly.
Lastly, the concurrent use of Dantrolene Sodium with other medications that can cause hepatotoxicity, such as certain antiepileptics and antibiotics, should be done with caution. Regular monitoring of liver enzymes is advised to detect any early signs of liver damage. Patients should be instructed to report any symptoms suggestive of liver dysfunction, such as jaundice, abdominal pain, or dark urine.
It is important for both patients and prescribers to be aware of these potential interactions when considering the use of Dantrolene Sodium 50 mg/ml Oral Liquid. Adjustments to therapy and close monitoring may be necessary to ensure safe and appropriate use of this medication. If you have any questions or require further information regarding drug interactions with Dantrolene Sodium, please reach out to us at Bayview Pharmacy for assistance.
Dantrolene Sodium is a muscle relaxant that works by directly affecting skeletal muscle function. It achieves this by blocking the release of calcium ions from the sarcoplasmic reticulum of skeletal muscle cells. This action inhibits the muscle contraction process at a molecular level, which in turn reduces the force of muscle contractions. In the 50 mg/ml oral liquid formulation, Dantrolene Sodium is suspended in a liquid carrier, which allows for the medication to be administered orally. This is particularly beneficial for patients who have difficulty swallowing pills, such as those with dysphagia, or for specific populations like children and the elderly who may require a more palatable or easier-to-administer form of medication.
The Dantrolene Sodium oral liquid formulation is primarily used in the treatment of conditions characterized by excessive muscle contractions, such as malignant hyperthermia, a life-threatening complication of certain anesthetic agents, and neuroleptic malignant syndrome, a similar reaction to some psychiatric drugs. It is also prescribed for the management of spasticity resulting from conditions like spinal cord injury, stroke, cerebral palsy, or multiple sclerosis. By reducing the muscle spasticity, patients experience relief from muscle pain and stiffness, which can improve their mobility and quality of life.
For prescribers, it is important to note that the efficacy of Dantrolene Sodium can be seen within the first week of treatment, but it may take longer for the full effects to be observed. The dosing should be individualized based on the patient's response and tolerance to the medication. As with any medication, monitoring for side effects is crucial, and patients should be advised of potential side effects such as drowsiness, dizziness, weakness, and potential liver toxicity. Regular liver function tests are recommended when using this medication.
Patients should be instructed to take the medication exactly as prescribed and to not alter the dose without consulting their healthcare provider. The oral liquid formulation should be measured with an accurate measuring device to ensure the correct dose is administered. It is also important for patients to report any side effects or concerns to their healthcare provider promptly.
At Bayview Pharmacy, we are committed to providing high-quality compounded medications tailored to meet the unique needs of each patient. If you have any questions about the Dantrolene Sodium 50 mg/ml Oral Liquid formulation or its use in treating specific disease states, please do not hesitate to reach out to us. Our team of knowledgeable compounding pharmacists is here to assist you with any inquiries or concerns you may have.
Dantrolene Sodium oral liquid is primarily used in the treatment of muscle spasticity associated with conditions such as multiple sclerosis, cerebral palsy, spinal cord injury, and stroke. It works by relaxing muscles and relieving muscle stiffness and spasms, facilitating movement and enhancing the overall quality of life for affected individuals.
This medication should be taken exactly as prescribed by a healthcare provider. The typical administration involves shaking the bottle well and using an oral syringe or dosing cup to measure the correct dosage. It can be taken with or without food, but consistency is key in how you take it in relation to meals.
Yes, Dantrolene Sodium oral liquid is specifically designed for patients who have difficulty swallowing pills, including the pediatric and geriatric populations, making medication adherence easier for these groups.
Common side effects may include drowsiness, dizziness, weakness, general malaise, or diarrhea. If any of these effects persist or worsen, or if you experience symptoms of liver problems, such as severe abdominal pain, persistent nausea/vomiting, or yellowing eyes/skin, contact your healthcare provider promptly.
Dantrolene Sodium oral liquid can be prescribed to children, but dosage will be carefully determined by a healthcare professional based on the child’s weight and medical condition.
Storage requirements can vary based on the specific formulation prepared by the pharmacy. You should follow the storage instructions provided by your pharmacist, which typically include storing the liquid at room temperature away from light and moisture, unless otherwise directed.
The onset of action for Dantrolene Sodium may differ from individual to individual. Some individuals might notice an improvement in muscle spasticity within a few days; however, it can take longer for the full benefits to be evident. Always discuss with your healthcare provider for personalized expectations.
It is possible for Dantrolene Sodium to interact with other medications or supplements, so it is important to inform your healthcare provider about all the medicines you are currently taking in order to avoid potential interactions.
If you miss a dose of Dantrolene Sodium, take it as soon as you remember. However, if it is nearly time for your next dose, skip the missed dose and resume your regular dosing schedule. Do not double the dose to catch up.
Dantrolene Sodium does not typically cause dependency; however, it should still be used strictly in accordance with your healthcare provider’s directions to avoid any potential misuse or adverse effects.
Alcohol consumption is not recommended while taking Dantrolene Sodium oral liquid, as it can enhance the nervous system side effects such as dizziness, drowsiness, and difficulty concentrating. In some cases, it may also cause liver damage. Always consult your healthcare provider for advice regarding alcohol intake.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
